CLL-1 targeted immunotherapies

Assignee

• Regeneron Pharmaceuticals
• Inhibrx Biosciences

Inventors

• Jordan Jarjour (21 patents)
• Mark Pogson (5 patents)
• Wai-Hang Leung (5 patents)
• Lucas Rascon (7 patents)
• Angelica Sanabria (8 patents)
• John C. Timmer (41 patents)
• Brendan P. Eckelman (44 patents)

View full patent text on Google Patents →